Testing effectiveness (Phase 2)Not Yet RecruitingNCT07522411
What this trial is testing
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
Who this might be right for
Hepatocellular Carcinoma
BinYong Liang 100